Targeting the eIF4F Translation Initiation Complex: A Critical Nexus for Cancer Development
Open accessAbstract
Elevated protein synthesis is an important feature of many cancer cells and often arises as a consequence of increased signaling flux channeled to eukaryotic initiation factor 4F (eIF4F), the key regulator of the mRNA–ribosome recruitment phase of translation initiation. In many cellular and preclinical models of cancer, eIF4F deregulation results in changes in translational efficiency of specific mRNA classes. Importantly, many of these mRNAs code for proteins that potently regulate critical cellular processes, such as cell growth and proliferation, enhanced cell survival and cell migration that ultimately impinge on several hallmarks of cancer, including increased angiogenesis, deregulated growth control, enhanced cellular survival, epithelial-to-mesenchymal transition, invasion, and metastasis. By being positioned as the molecular nexus downstream of key oncogenic signaling pathways (e.g., Ras, PI3K/AKT/TOR, and MYC), eIF4F serves as a direct link between important steps in cancer development and translation initiation. Identification of mRNAs particularly responsive to elevated eIF4F activity that typifies tumorigenesis underscores the critical role of eIF4F in cancer and raises the exciting possibility of developing new-in-class small molecules targeting translation initiation as antineoplastic agents. Cancer Res; 75(2); 250–63. ©2014 AACR.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Many direct eIF4A/eIF4F mRNA targets have been identified and often encode proteins that drive proliferation, metastasis, and survival.
“Many direct eIF4A/eIF4F mRNA targets have been identified and often encode proteins that drive proliferation, metastasis, and survival (11, 14, 15).”
From Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancer (2023) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
2 retracted
Pardo, O. E., Arcaro, A., Salerno, G., Raguz, S., Downward, J., & Seckl, M. J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.a115.109006 · Cited by 153 · see citing works
RetractedPardo, O. E., Arcaro, A., Salerno, G., Raguz, S., Downward, J., & Seckl, M. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109006200 · Cited by 145 · see citing works
RetractedThe landscape of somatic copy-number alteration across human cancers
Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature · doi:10.1038/nature08822 · Cited by 4,017 · see citing works
Defining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833 · see citing works
Molecular mechanisms of mTOR-mediated translational control
Ma, X. M., & Blenis, J. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2672 · Cited by 2,558 · see citing works
eIF4 Initiation Factors: Effectors of mRNA Recruitment to Ribosomes and Regulators of Translation
Gingras, A., Raught, B., & Sonenberg, N. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.913 · Cited by 2,103 · see citing works
Self-citationA unifying model for mTORC1-mediated regulation of mRNA translation
Thoreen, C. C., Chantranupong, L., Keys, H. R., Wang, T., Gray, N. S., & Sabatini, D. M. (2012) · Nature · doi:10.1038/nature11083 · Cited by 1,477 · see citing works
Regulation of 4E-BP1 phosphorylation: a novel two-step mechanismPreprint
Gingras, A., Gygi, S. P., Raught, B., Polakiewicz, R. D., Abraham, R. T., Hoekstra, M. F., Aebersold, R. H., & Sonenberg, N. (1999) · Genes & Development · doi:10.1101/gad.13.11.1422 · Cited by 1,348 · see citing works
Self-citationThe translational landscape of mTOR signalling steers cancer initiation and metastasis
Hsieh, A. C., Liu, Y., Edlind, M. P., Ingolia, N. T., Janes, M. R., Sher, A., Shi, E. Y., Stumpf, C. R., Christensen, C., Bonham, M. J., et al. (2012) · Nature · doi:10.1038/nature10912 · Cited by 1,313 · see citing works
Self-citationPhosphorylation and Functional Inactivation of TSC2 by Erk
Ma, L., Chen, Z., Erdjument-Bromage, H., Tempst, P., & Pandolfi, P. P. (2005) · Cell · doi:10.1016/j.cell.2005.02.031 · Cited by 1,268 · see citing works
Holz, M. K., Ballif, B. A., Gygi, S. P., & Blenis, J. (2005) · Cell · doi:10.1016/j.cell.2005.10.024 · Cited by 1,262 · see citing works
Dang, C. V., O’Donnell, K. A., Zeller, K. I., Nguyen, T., Osthus, R. C., & Li, F. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.014 · Cited by 1,188 · see citing works
Shatkin, A. J. (1976) · Cell · doi:10.1016/0092-8674(76)90128-8 · Cited by 1,180 · see citing works
Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap
Lazaris-Karatzas, A., Montine, K. S., & Sonenberg, N. (1990) · Nature · doi:10.1038/345544a0 · Cited by 965 · see citing works
Self-citationSurvival signalling by Akt and eIF4E in oncogenesis and cancer therapy
Wendel, H., de Stanchina, E., Fridman, J. S., Malina, A., Ray, S., Kogan, S. C., Cordon‐Cardo, C., Pelletier, J., & Lowe, S. W. (2004) · Nature · doi:10.1038/nature02369 · Cited by 956 · see citing works
Self-citationMorita, M., Gravel, S.-P., Chénard, V., Sikström, K., Zheng, L., Alain, T., Gandin, V., Avizonis, D., Arguello, M., Zakaria, C., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.10.001 · Cited by 842 · see citing works
Self-citationTranslational control in cancer
Silvera, D., Formenti, S. C., & Schneider, R. J. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2824 · Cited by 820 · see citing works
S6K1- and ßTRCP-Mediated Degradation of PDCD4 Promotes Protein Translation and Cell Growth
Dorrello, N. V., Peschiaroli, A., Guardavaccaro, D., Colburn, N. H., Sherman, N. E., & Pagano, M. (2006) · Science · doi:10.1126/science.1130276 · Cited by 731 · see citing works
eIF-4E expression and its role in malignancies and metastases
Benedetti, A. D., & Graff, J. R. (2004) · Oncogene · doi:10.1038/sj.onc.1207545 · Cited by 728 · see citing works
Self-citationAssociation of the yeast poly(A) tail binding protein with translation initiation factor eIF‐4G.
Tarun, S. Z., & Sachs, A. B. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01108.x · Cited by 690 · see citing works
Influences of mRNA secondary structure on initiation by eukaryotic ribosomes.
Kozak, M. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.9.2850 · Cited by 687 · see citing works
Cocrystal Structure of the Messenger RNA 5′ Cap-Binding Protein (eIF4E) Bound to 7-methyl-GDP
Marcotrigiano, J., Gingras, A., Sonenberg, N., & Burley, S. K. (1997) · Cell · doi:10.1016/s0092-8674(00)80280-9 · Cited by 676 · see citing works
Self-citationHuman eukaryotic translation initiation factor 4G (eIF4G) recruits Mnk1 to phosphorylate eIF4E
Pyronnet, S., Imataka, H., Gingras, A., Fukunaga, R., Hunter, T., & Sonenberg, N. (1999) · The EMBO Journal · doi:10.1093/emboj/18.1.270 · Cited by 639 · see citing works
Self-citationRNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer
Wolfe, A. L., Singh, K., Zhong, Y., Drewe, P., Rajasekhar, V. K., Sanghvi, V. R., Mavrakis, K. J., Jiang, M., Roderick, J. E., Van der Meulen, J., et al. (2014) · Nature · doi:10.1038/nature13485 · Cited by 635 · see citing works
Self-citationBidirectional RNA Helicase Activity of Eucaryotic Translation Initiation Factors 4A and 4F
Rozen, F., Edery, I., Meerovitch, K., Dever, T. E., Merrick, W. C., & Sonenberg, N. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.3.1134 · Cited by 632 · see citing works
Self-citationMutational analysis of a DEAD box RNA helicase: the mammalian translation initiation factor eIF‐4A.
Pause, A., & Sonenberg, N. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05330.x · Cited by 615 · see citing works
Self-citationPelletier, J., & Sonenberg, N. (1985) · Cell · doi:10.1016/0092-8674(85)90200-4 · Cited by 610 · see citing works
Self-citationThe translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis
Ruggero, D., Montanaro, L., Ma, L., Xu, W. G., Londei, P., Cordon‐Cardo, C., & Pandolfi, P. P. (2004) · Nature Medicine · doi:10.1038/nm1042 · Cited by 592 · see citing works
Self-citationPestova, T., & Kolupaeva, V. (2002) · Genes & Development · doi:10.1101/gad.1020902 · Cited by 590 · see citing works
Moerke, N., Aktas, H., Chen, H., Cantel, S., Reibarkh, M., Fahmy, A., Gross, J., Degterev, A., Yuan, J., Chorev, M., et al. (2007) · Cell · doi:10.1016/j.cell.2006.11.046 · Cited by 568 · see citing works
Barrans, S., Crouch, S., Smith, A. G., Turner, K., Owen, R. G., Patmore, R. D., Roman, E., & Jack, A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.3947 · Cited by 552 · see citing works
The Molecular Mechanics of Eukaryotic Translation
Kapp, L. D., & Lorsch, J. R. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.030403.080419 · Cited by 540 · see citing works
The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity
Shahbazian, D., Roux, P. P., Mieulet, V., Cohen, M. S., Raught, B., Taunton, J., Hershey, J. W. B., Blenis, J., Pende, M., & Sonenberg, N. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601166 · Cited by 532 · see citing works
Self-citationeIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression
Furic, L., Rong, L., Larsson, O. S., Koumakpayi, I. H., Yoshida, K., Brueschke, A., Petroulakis, E., Robichaud, N., Pollak, M., Gaboury, L. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005320107 · Cited by 528 · see citing works
Self-citationDissecting eIF4E action in tumorigenesis.Preprint
Wendel, H., Silva, R. L. A., Malina, A., Mills, J., Zhu, H., Ueda, T., Watanabe‐Fukunaga, R., Fukunaga, R., Teruya-Feldstein, J., Pelletier, J., et al. (2007) · Genes & Development · doi:10.1101/gad.1604407 · Cited by 512 · see citing works
Self-citationMuise‐Helmericks, R. C., Grimes, H. L., Bellacosa, A., Malstrom, S. E., Tsichlis, P. N., & Rosen, N. X. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29864 · Cited by 511 · see citing works
Ueda, T., Watanabe-Fukunaga, R., Fukuyama, H., Nagata, S., & Fukunaga, R. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.15.6539-6549.2004 · Cited by 507 · see citing works
Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells.
Hann, S., & Eisenman, R. N. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.11.2486 · Cited by 503 · see citing works
Yang, H.-S., Jansen, A. P., Komar, A. A., Zheng, X., Merrick, W. C., Costes, S., Lockett, S. J., Sonenberg, N., & Colburn, N. H. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.26-37.2003 · Cited by 494 · see citing works
Self-citationKahvejian, A., Svitkin, Y. V., Sukarieh, R., M'Boutchou, M.-N., & Sonenberg, N. (2005) · Genes & Development · doi:10.1101/gad.1262905 · Cited by 491 · see citing works
Self-citationDuncan, R., Milburn, S. C., & Hershey, J. W. B. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)75938-9 · Cited by 483 · see citing works
Svitkin, Y. V., Pause, A., Haghighat, A., Pyronnet, S., Witherell, G. W., Belsham, G. J., & Sonenberg, N. (2001) · RNA · doi:10.1017/s135583820100108x · Cited by 477 · see citing works
Self-citationWaskiewicz, A. J., Johnson, J. C., Penn, B. H., Mahalingam, M., Kimball, S. R., & Cooper, J. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1871 · Cited by 469 · see citing works
Hsieh, A. C., Costa, M. D., Zollo, O., Davis, C. B., Feldman, M. E., Testa, J. R., Meyuhas, O., Shokat, K. M., & Ruggero, D. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.021 · Cited by 464 · see citing works
Self-citationEvdokimova, V. E., Tognon, C. E., Ng, T., Ruzanov, P., Melnyk, N., Fink, D., Sorokin, A. V., Ovchinnikov, L. P., Davicioni, E., Triche, T. J., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.017 · Cited by 444 · see citing works
Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency
Barna, M., Pusic, A., Zollo, O., Costa, M. J., Kondrashov, N., Rego, E., Rao, P., & Ruggero, D. (2008) · Nature · doi:10.1038/nature07449 · Cited by 434 · see citing works
Self-citationRajasekhar, V. K., Viale, A., Socci, N. D., Wiedmann, M., Hu, X., & Holland, E. C. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00395-2 · Cited by 420 · see citing works
New initiation factor activity required for globin mRNA translation.
GRIFO, J. A., Tahara, S. M., Morgan, M. A., Shatkin, A. J., & Merrick, W. C. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)81965-6 · Cited by 406 · see citing works
Rousseau, D. L., Kaspar, R. L., Rosenwald, I. B., Gehrke, L., & Sonenberg, N. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1065 · Cited by 401 · see citing works
Self-citationATP-dependent unwinding of messenger RNA structure by eukaryotic initiation factors.
Ray, B. K., Lawson, T. G., Kramer, J. C., Hadzopoulou‐Cladaras, M., GRIFO, J. A., Abramson, R. D., Merrick, W. C., & Thach, R. E. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39658-8 · Cited by 399 · see citing works
Graff, J., Konicek, B., Vincent, T. M., Lynch, R. L., Monteith, D., Weir, S., Schwier, P., Capen, A., Goode, R., Dowless, M., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32044 · Cited by 393 · see citing works
Self-citationPrinciples of Translational Control: An OverviewPreprint
Hershey, J. W. B., Sonenberg, N., & Mathews, M. B. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a011528 · Cited by 390 · see citing works
Self-citationStructure of translation factor elF4E bound to m7GDP and interaction with 4E-binding protein
Matsuo, H., Li, H., Manson, A. L., Fletcher, C. M., Gingras, A., Sonenberg, N., & Wagner, G. (1997) · Nature Structural Biology · doi:10.1038/nsb0997-717 · Cited by 378 · see citing works
Self-citationA common function for mRNA 5' and 3' ends in translation initiation in yeast.Preprint
Tarun, S. Z., & Sachs, A. B. (1995) · Genes & Development · doi:10.1101/gad.9.23.2997 · Cited by 374 · see citing works
eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies
Boussemart, L., Malka-Mahieu, H., Girault, I., Allard, D., Hemmingsson, O., Tomasic, G., Thomas, M., Basmadjian, C., Ribeiro, N., Thuaud, F., et al. (2014) · Nature · doi:10.1038/nature13572 · Cited by 373 · see citing works
Functional characterization of IRESes by an inhibitor of the RNA helicase eIF4A
Bordeleau, M.-È., Mori, A., Oberer, M., Lindqvist, L., Chard, L. S., Higa, T., Belsham, G. J., Wagner, G., Tanaka, J., & Pelletier, J. (2006) · Nature Chemical Biology · doi:10.1038/nchembio776 · Cited by 370 · see citing works
Self-citationAvdulov, S. V., Li, S., Michalek, V. N., Burrichter, D., Peterson, M., Perlman, D., Manivel, J. C., Sonenberg, N., Yee, D., Bitterman, P. B., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.05.024 · Cited by 341 · see citing works
Self-citationModulation of the Helicase Activity of eIF4A by eIF4B, eIF4H, and eIF4F
Rogers, G. W., Richter, N. J., Lima, W. F., & Merrick, W. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100157200 · Cited by 339 · see citing works
Rogers, G. W., Richter, N. J., & Merrick, W. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12236 · Cited by 337 · see citing works
Bordeleau, M.-È., Robert, F., Gerard, B., Lindqvist, L., Chen, S. M. H., Wendel, H., Brem, B., Greger, H., Lowe, S. W., Porco, J. A. J., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34753 · Cited by 335 · see citing works
Self-citationTargeting the Eukaryotic Translation Initiation Factor 4E for Cancer Therapy
Graff, J. R., Konicek, B. W., Carter, J. H., & Marcusson, E. G. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5635 · Cited by 333 · see citing works
Self-citationL-asparaginase therapy for leukemia and other malignant neoplasms. Remission in human leukemia
Hill, J. M. (1967) · JAMA · doi:10.1001/jama.202.9.882 · Cited by 322 · see citing works
Osteopontin: regulation in tumor metastasis
Wai, P. Y., & Kuo, P. C. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9104-9 · Cited by 321 · see citing works
Kentsis, A., Topisirović, I., Čuljković, B., Shao, L., & Borden, K. L. B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406927102 · Cited by 311 · see citing works
Does phosphorylation of the cap‐binding protein eIF4E play a role in translation initiation?
Scheper, G. C., & Proud, C. G. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03291.x · Cited by 310 · see citing works
Kugaya, A., Akechi, T., Okuyama, T., Nakano, T., Mikami, I., Okamura, H., & Uchitomi, Y. (2000) · Cancer · doi:10.1002/1097-0142(20000615)88:12 · Cited by 309 · see citing works
Antitumor Activity and Mechanism of Action of the Cyclopenta[b]benzofuran, Silvestrol
Cencic, R., Carrier, M., Galicia-Vázquez, G., Bordeleau, M.-E., Sukarieh, R., Bourdeau, A., Brem, B., Teodoro, J. G., Greger, H., Tremblay, M. L., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005223 · Cited by 302 · see citing works
Self-citationA Novel Functional Human Eukaryotic Translation Initiation Factor 4G
Gradi, A., Imataka, H., Svitkin, Y. V., Rom, E., Raught, B., Morino, S., & Sonenberg, N. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.334 · Cited by 296 · see citing works
Self-citationImataka, H., & Sonenberg, N. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.12.6940 · Cited by 292 · see citing works
Self-citationPourdehnad, M., Truitt, M., Siddiqi, I. N., Ducker, G. S., Shokat, K. M., & Ruggero, D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310230110 · Cited by 288 · see citing works
Self-citationRosenwald, I. B., Lazaris-Karatzas, A., Sonenberg, N., & Schmidt, E. V. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7358 · Cited by 287 · see citing works
Self-citation4E-Binding Protein 1: A Key Molecular “Funnel Factor” in Human Cancer with Clinical Implications
Armengol, G., Rojo, F., Castellví, J., Iglesias, C., Cuatrecasas, M., Pons, B., Baselga, J. M., & y Cajal, S. R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0881 · Cited by 272 · see citing works
Topisirovic, I., Ruiz-Gutierrez, M., & Borden, K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2677 · Cited by 267 · see citing works
Sonenberg, N., Rupprecht, K. M., Hecht, S. M., & Shatkin, A. J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4345 · Cited by 261 · see citing works
Self-citationCunningham, J. T., Moreno, M. V., Lodi, A., Ronen, S. M., & Ruggero, D. (2014) · Cell · doi:10.1016/j.cell.2014.03.052 · Cited by 260 · see citing works
Self-citationCap-Binding Proteins of Eukaryotic Messenger RNA: Functions in Initiation and Control of Translation
Sonenberg, N. (1988) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(08)60614-5 · Cited by 259 · see citing works
Self-citationPhosphorylation of eIF4E promotes EMT and metastasis via translational control of SNAIL and MMP-3
Robichaud, N., Rincon, S. V. D., Huor, B., Alain, T., Petruccelli, L. A., Hearnden, J., Gonçalves, C., Grotegut, S., Spruck, C., Furic, L., et al. (2014) · Oncogene · doi:10.1038/onc.2014.146 · Cited by 259 · see citing works
Self-citationPhosphorylation of Eukaryotic Initiation Factor 4E Markedly Reduces Its Affinity for Capped mRNA
Scheper, G. C., van Kollenburg, B., Hu, J., Luo, Y., Goss, D. J., & Proud, C. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m103607200 · Cited by 257 · see citing works
Rosenwald, I. B., Rhoads, D. B., Callanan, L., Isselbacher, K. J., & Schmidt, E. V. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.6175 · Cited by 256 · see citing works
Tcherkezian, J., Cargnello, M., Roméo, Y., Huttlin, E. L., Lavoie, G., Gygi, S. P., & Roux, P. P. (2014) · Genes & Development · doi:10.1101/gad.231407.113 · Cited by 255 · see citing works
Knauf, U., Tschopp, C., & Gram, H. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.16.5500-5511.2001 · Cited by 249 · see citing works
Topology and regulation of the human eIF4A/4G/4H helicase complex in translation initiation
Marintchev, A., Edmonds, K., Marintcheva, B., Hendrickson, E., Oberer, M., Suzuki, C., Herdy, B., Sonenberg, N., & Wagner, G. (2009) · Cell · doi:10.1016/j.cell.2009.01.014 · Cited by 248 · see citing works
Self-citationEssential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer
Silvera, D., Arju, R., Darvishian, F., Levine, P. H., Zolfaghari, L., Goldberg, J. D., Hochman, T., Formenti, S. C., & Schneider, R. J. (2009) · Nature Cell Biology · doi:10.1038/ncb1900 · Cited by 244 · see citing works
Translational control of immune responses: from transcripts to translatomes
Piccirillo, C. A., Bjur, E., Topisirović, I., Sonenberg, N., & Larsson, O. S. (2014) · Nature Immunology · doi:10.1038/ni.2891 · Cited by 244 · see citing works
Self-citationeIF4G Dramatically Enhances the Binding of eIF4E to the mRNA 5′-Cap Structure
Haghighat, A., & Sonenberg, N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.21677 · Cited by 239 · see citing works
Self-citationJones, R. M., Branda, J. A., Johnston, K. A., Polymenis, M., Gadd, M. A., Rustgi, A. K., Callanan, L., & Schmidt, E. V. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4754 · Cited by 237 · see citing works
Bordeleau, M.-È., Matthews, J., Wojnar, J. M., Lindqvist, L., Novac, O., Jankowsky, E., Sonenberg, N., Northcote, P. T., Teesdale‐Spittle, P. H., & Pelletier, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504249102 · Cited by 229 · see citing works
Self-citationTahara, S. M., Morgan, M. A., & Shatkin, A. J. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43324-8 · Cited by 228 · see citing works
Bidirectional RNA Helicase Activity of Eucaryotic Translation Initiation Factors 4A and 4F
Rozen, F., Edery, I., Meerovitch, K., et al. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.3.1134-1144.1990 · Cited by 225 · see citing works
Epigenetic Activation of a Subset of mRNAs by eIF4E Explains Its Effects on Cell Proliferation
Mamane, Y., Petroulakis, E., Martineau, Y., Sato, T., Larsson, O. S., Rajasekhar, V. K., & Sonenberg, N. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000242 · Cited by 222 · see citing works
Self-citationInvolvement of eukaryotic initiation factor 4A in the cap recognition process.
Edery, I., Hümbelin, M., Darveau, A., Lee, K. A. W., Milburn, S. C., Hershey, J. W. B., Trachsel, H., & Sonenberg, N. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44431-0 · Cited by 221 · see citing works
Self-citationPhosphorylation of Eukaryotic Protein Synthesis Initiation Factor 4E at Ser-209
Joshi, B., Cai, A., Keiper, B. D., Minich, W. B., Méndez, R., Beach, C. M., Stȩpiński, J., Stolarski, R., Darżynkiewicz, E., & Rhoads, R. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.24.14597 · Cited by 216 · see citing works
Graff, J. R., & Zimmer, S. G. (2003) · Clinical & Experimental Metastasis · doi:10.1023/a:1022943419011 · Cited by 215 · see citing works
Self-citationIlić, N., Utermark, T., Widlund, H. R., & Roberts, T. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108237108 · Cited by 213 · see citing works
Ueda, T., Sasaki, M., Elia, A., Chio, I. I. C., Hamada, K., Fukunaga, R., & Mak, T. W. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008136107 · Cited by 209 · see citing works
Shantz, L. M., & Pegg, A. E. (1994) · PubMed · Cited by 205 · see citing works
Graff, J. R., Konicek, B. W., Lynch, R. L., Dumstorf, C. A., Dowless, M. S., McNulty, A. M., Parsons, S. H., Brail, L. H., Colligan, B. M., Koop, J. W., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3472 · Cited by 204 · see citing works
Self-citationRubio, C. A., Weisburd, B., Holderfield, M., Arias, C., Fang, E., DeRisi, J. L., & Fanidi, A. (2014) · Genome Biology · doi:10.1186/s13059-014-0476-1 · Cited by 200 · see citing works
Influence of mRNA secondary structure on binding and migration of 40S ribosomal subunits
Kozak, M. (1980) · Cell · doi:10.1016/0092-8674(80)90390-6 · Cited by 199 · see citing works
Duncan, R., & Hershey, J. W. B. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32356-1 · Cited by 195 · see citing works
Konicek, B. W., Stephens, J. R., McNulty, A. M., Robichaud, N., Peery, R. B., Dumstorf, C. A., Dowless, M. S., Iversen, P. W., Parsons, S. H., Ellis, K. E., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3298 · Cited by 193 · see citing works
Self-citationeIF4GI links nutrient sensing by mTOR to cell proliferation and inhibition of autophagy
Ramírez‐Valle, F., Braunstein, S. E., Zavadil, J., Formenti, S. C., & Schneider, R. J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200710215 · Cited by 191 · see citing works
Reversing chemoresistance by small molecule inhibition of the translation initiation complex eIF4F
Cencic, R., Hall, D. R., Robert, F., Du, Y., Min, J., Li, L., Qui, M., Lewis, I., Kurtkaya, S., Dingledine, R. J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011477108 · Cited by 188 · see citing works
Self-citationGrolleau‐Julius, A., Bowman, J., Pradet‐Balade, B., Puravs, E., Hanash, S., García‐Sanz, J. A., & Beretta, L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202014200 · Cited by 187 · see citing works
O'Brien, S. M., Kantarjian, H. M., Keating, M., Beran, M., Koller, C. A., Robertson, L. E., Hester, J. P., Rios, M., Andreeff, M., & Talpaz, M. (1995) · Blood · doi:10.1182/blood.v86.9.3322.bloodjournal8693322 · Cited by 182 · see citing works
General RNA binding proteins render translation cap dependent.
Svitkin, Y. V., Ovchinnikov, L. P., Dreyfuss, G., & Sonenberg, N. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01106.x · Cited by 180 · see citing works
Self-citationc-Myc and eIF4F Are Components of a Feedforward Loop that Links Transcription and Translation
Lin, C.-J., Cencic, R., Mills, J. R., Robert, F., & Pelletier, J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5876 · Cited by 180 · see citing works
Self-citationParkin, N. T., Cohen, É. A., Darveau, A., Rosen, C. A., Haseltine, W. A., & Sonenberg, N. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03139.x · Cited by 177 · see citing works
Self-citationMYC regulation of a “poor-prognosis” metastatic cancer cell state
Wolfer, A., Wittner, B. S., Irimia, D., Flavin, R., Lupien, M., Gunawardane, R. N., Meyer, C. A., Lightcap, E. S., Tamayo, P., Mesirov, J. P., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914203107 · Cited by 176 · see citing works
Rosenwald, I. B., Chen, J.-J., Wang, S., Savas, L., London, I. M., & Pullman, J. M. (1999) · Oncogene · doi:10.1038/sj.onc.1202563 · Cited by 173 · see citing works
Lucas, D. M., Edwards, R. B., Lozanski, G., West, D. A., Shin, J. D., Vargo, M. A., Davis, M. E., Rozewski, D. M., Johnson, A. J., Su, B., et al. (2009) · Blood · doi:10.1182/blood-2008-09-175430 · Cited by 173 · see citing works
Human eIF4E promotes mRNA restructuring by stimulating eIF4A helicase activity
Feoktistova, K., Tuvshintogs, E., Do, A., & Fraser, C. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303781110 · Cited by 169 · see citing works
Zimmer, S. G., DeBenedetti, A., & Graff, J. R. (2000) · PubMed · Cited by 167 · see citing works
Self-citationPolunovsky, V. A., Rosenwald, I. B., Tan, A., White, J. G., Chiang, L., Sonenberg, N., & Bitterman, P. B. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.11.6573 · Cited by 165 · see citing works
Self-citationPDCD4 inhibits translation initiation by binding to eIF4A using both its MA3 domains
Suzuki, C., Garces, R. G., Edmonds, K. A., Hiller, S., Hyberts, S. G., Marintchev, A., & Wagner, G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712235105 · Cited by 165 · see citing works
Nielsen, P. J., McMaster, G., & Trachsel, H. (1985) · Nucleic Acids Research · doi:10.1093/nar/13.19.6867 · Cited by 159 · see citing works
Malignant transformation by overproduction of translation initiation factor eIF4G.
Shimogori, T., Ishii, I., Kashiwagi, K., Mashiba, H., EKIMOTO, H., & Igarashi, K. (1997) · PubMed · Cited by 159 · see citing works
eIF4E/4E-BP Ratio Predicts the Efficacy of mTOR Targeted Therapies
Alain, T., Morita, M., Fonseca, B. D., Yanagiya, A., Siddiqui, N., Bhat, M., Zammit, D., Marcus, V., Metrakos, P. P., Voyer, L.-A., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2395 · Cited by 158 · see citing works
Self-citationBenedetti, A. D., Joshi‐Barve, S., Rinker-Schaeffer, C. W., & Rhoads, R. E. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.11.5435-5445.1991 · Cited by 157 · see citing works
RNA-mediated sequestration of the RNA helicase eIF4A by Pateamine A inhibits translation initiation.
Bordeleau, M.-È., Cencic, R., Lindqvist, L., Oberer, M., Northcote, P., Wagner, G., & Pelletier, J. (2006) · Chemistry and Biology · doi:10.1016/j.chembiol.2006.10.005 · Cited by 154 · see citing works
Self-citationFlynn, A., & Proud, C. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.37.21684 · Cited by 152 · see citing works
ATP/Mg++-dependent cross-linking of cap binding proteins to the 5′ end of eukaryotic mRNA
Sonenberg, N. (1981) · Nucleic Acids Research · doi:10.1093/nar/9.7.1643 · Cited by 150 · see citing works
Self-citationLawson, T. G., Ray, B. K., Dodds, J. T., GRIFO, J. A., Abramson, R. D., Merrick, W. C., Betsch, D. F., Weith, H. L., & Thach, R. E. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)66969-8 · Cited by 147 · see citing works
Further Characterization of the Helicase Activity of eIF4A
Rogers, G. W., Lima, W. F., & Merrick, W. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007560200 · Cited by 145 · see citing works
DEAD-box proteins can completely separate an RNA duplex using a single ATP
Chen, Y., Potratz, J. P., Tijerina, P., Campo, M. D., Lambowitz, A. M., & Russell, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811075106 · Cited by 143 · see citing works
Proteins Encoded by the Human c-myc Oncogene: Differential Expression in Neoplastic Cells
Hann, S., & Eisenman, R. N. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.11.2486-2497.1984 · Cited by 143 · see citing works
Inhibitors of protein synthesis identified by a high throughput multiplexed translation screen
Novac, O. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh235 · Cited by 141 · see citing works
The p46 subunit of eukaryotic initiation factor (eIF)-4F exchanges with eIF-4A.
Yoder-Hill, J., Pause, A., Sonenberg, N., & Merrick, W. C. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53358-5 · Cited by 140 · see citing works
Self-citationHong, D. S., Kurzrock, R., Oh, Y. W., Wheler, J. J., Naing, A., Brail, L. H., Callies, S., André, V., KADAM, S. K., Nasir, A., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0430 · Cited by 140 · see citing works
Tomoo, K., Shen, X., Okabe, K., Nozoe, Y., Fukuhara, S., Morino, S., Ishida, T., Taniguchi, T., Hasegawa, H., Terashima, A., et al. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3620539 · Cited by 139 · see citing works
Control of Cell Survival and Proliferation by Mammalian Eukaryotic Initiation Factor 4B
Shahbazian, D., Parsyan, A. E., Petroulakis, E., Topisirović, I., Martineau, Y., Gibbs, B. F., Svitkin, Y. V., & Sonenberg, N. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01218-09 · Cited by 137 · see citing works
Self-citationKevil, C. G., Carter, P. M., Hu, B., & Benedetti, A. D. (1995) · PubMed · Cited by 131 · see citing works
Immunophilins: Switched on protein binding domains?
Ivery, M. T. G. (2000) · Medicinal Research Reviews · doi:10.1002/1098-1128(200011)20:6 · Cited by 130 · see citing works
Zuberek, J., Wysłouch‐Cieszyńska, A., Niedźwiecka-Kornaś, A., Dadlez, M., Stȩpiński, J., Augustyniak, W., Gingras, A., ZHANG, Z., Burley, S. K., Sonenberg, N., et al. (2003) · RNA · doi:10.1261/rna.2133403 · Cited by 129 · see citing works
Self-citationEvidence for a Functionally Relevant Rocaglamide Binding Site on the eIF4A–RNA Complex
Sadlish, H., Galicia-Vázquez, G., PARIS, C. G., Aust, T., Bhullar, B., Chang, L., Helliwell, S. B., Hoepfner, D., Knapp, B., Riedl, R., et al. (2013) · ACS Chemical Biology · doi:10.1021/cb400158t · Cited by 127 · see citing works
Self-citationWakiyama, M., Imataka, H., & Sonenberg, N. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00701-6 · Cited by 126 · see citing works
Self-citationBorman, A. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.21.4068 · Cited by 125 · see citing works
A cellular response linking eIF4AI activity to eIF4AII transcription
Galicia-Vázquez, G., Cencic, R., Robert, F., Agenor, A., & Pelletier, J. (2012) · RNA · doi:10.1261/rna.033209.112 · Cited by 119 · see citing works
Self-citationYanagiya, A., Svitkin, Y. V., Shibata, S., Mikami, S., Imataka, H., & Sonenberg, N. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01187-08 · Cited by 116 · see citing works
Self-citationUnique translation initiation of mRNAs-containing TISU element
Elfakess, R., Sinvani, H., Haimov, O., Svitkin, Y. V., Sonenberg, N., & Dikstein, R. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr484 · Cited by 115 · see citing works
Self-citationLi, S., Takasu, T., Perlman, D., Peterson, M. S., Burrichter, D., Avdulov, S. V., Bitterman, P. B., & Polunovsky, V. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208821200 · Cited by 114 · see citing works
Graff, J. R., Boghaert, E. R., Benedetti, A. D., Tudor, D., Zimmer, C. C., Chan, S. K., & Zimmer, S. G. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600221 · Cited by 114 · see citing works
Self-citationRinker-Schaeffer, C. W., Graff, J. R., Benedetti, A. D., Zimmer, S. G., & Rhoads, R. E. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910550525 · Cited by 114 · see citing works
Self-citationBlocking eIF4E-eIF4G Interaction as a Strategy To Impair Coronavirus Replication
Cencic, R., Desforges, M., Hall, D. R., Kozakov, D., Du, Y., Min, J., Dingledine, R. J., Fu, H., Vajda, S., Talbot, P. J., et al. (2011) · Journal of Virology · doi:10.1128/jvi.00078-11 · Cited by 108 · see citing works
Self-citationMaga, G., Falchi, F., Radi, M., Botta, L., Casaluce, G., Bernardini, M., Irannejad, H., Manetti, F., Garbelli, A., Samuele, A., et al. (2011) · ChemMedChem · doi:10.1002/cmdc.201100166 · Cited by 107 · see citing works
Altman, J. K., Szilard, A., Konicek, B. W., Iversen, P. W., Kroczyńska, B., Glaser, H., Sassano, A., Vakana, E., Graff, J. R., & Platanias, L. C. (2013) · Blood · doi:10.1182/blood-2013-01-477216 · Cited by 106 · see citing works
Self-citationTan, A., Bitterman, P. B., Sonenberg, N., Peterson, M., & Polunovsky, V. A. (2000) · Oncogene · doi:10.1038/sj.onc.1203446 · Cited by 106 · see citing works
Self-citationKuznetsov, G., Xu, Q., Rudolph-Owen, L., TenDyke, K., Liu, J., Towle, M. J., Zhao, N., Marsh, J. P., Agoulnik, S. I., Twine, N. C., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1026 · Cited by 105 · see citing works
Differential stimulation of capped mRNA translation in vitro by cap binding protein
Sonenberg, N., Trachsel, H., Hecht, S. M., & Shatkin, A. J. (1980) · Nature · doi:10.1038/285331a0 · Cited by 104 · see citing works
Self-citationElfakess, R., & Dikstein, R. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003094 · Cited by 104 · see citing works
Tumor suppression by small molecule inhibitors of translation initiation
Chen, L., Aktas, B. H., Wang, Y., He, X., Sahoo, R., Zhang, N., Denoyelle, S., Kabha, E., Yang, H., Yefidoff‐Freedman, R., et al. (2012) · Oncotarget · doi:10.18632/oncotarget.598 · Cited by 104 · see citing works
Pelletier, J., & Sonenberg, N. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.11.3222-3230.1985 · Cited by 102 · see citing works
Self-citationLi, S., Sonenberg, N., Gingras, A., Peterson, M., Avdulov, S. V., Polunovsky, V. A., & Bitterman, P. B. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2853-2861.2002 · Cited by 99 · see citing works
Self-citationInteractions between eIF4AI and its accessory factors eIF4B and eIF4H
Rozovsky, N., Butterworth, A. C., & Moore, M. J. (2008) · RNA · doi:10.1261/rna.1049608 · Cited by 97 · see citing works
Determinants of Sensitivity and Resistance to Rapamycin-Chemotherapy Drug Combinations In vivo
Wendel, H., Malina, A., Zhao, Z., Zender, L., Kogan, S. C., Cordon‐Cardo, C., Pelletier, J., & Lowe, S. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0419 · Cited by 96 · see citing works
Self-citationMultiple elements in the eIF4G1 N‐terminus promote assembly of eIF4G1•PABP mRNPs in vivo
Park, E.-H., Walker, S. E., Lee, J. M., Rothenburg, S., Lorsch, J. R., & Hinnebusch, A. G. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.312 · Cited by 92 · see citing works
Targeting Synthetic Lethal Interactions between Myc and the eIF4F Complex Impedes Tumorigenesis
Lin, C., Nasr, Z., Premsrirut, P. K., Porco, J. A. J., Hippo, Y., Lowe, S. W., & Pelletier, J. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.02.010 · Cited by 91 · see citing works
Self-citationEffects of hippuristanol, an inhibitor of eIF4A, on adult T-cell leukemia
Tsumuraya, T., Ishikawa, C., Machijima, Y., Nakachi, S., Senba, M., Tanaka, J., & Mori, N. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.12.025 · Cited by 91 · see citing works
Shui, L., Jia, Y., Jacobson, B. A., McCauley, J. A., Kratzke, R. A., Bitterman, P. B., & Wagner, C. R. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300699d · Cited by 88 · see citing works
Oncogenic Activation of MEK/ERK Primes Melanoma Cells for Adaptation to Endoplasmic Reticulum Stress
Croft, A. J., Tay, K. H., Boyd, S. C., Guo, S., Jiang, C. C., Lai, F., Tseng, H., Jin, L., Rizos, H., Hersey, P., et al. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.325 · Cited by 87 · see citing works
DeFatta, R. J., Nathan, C. O., & Benedetti, A. D. (2000) · The Laryngoscope · doi:10.1097/00005537-200006000-00007 · Cited by 87 · see citing works
Ghosh, B. K., Benyumov, A. O., Ghosh, P., Jia, Y., Avdulov, S. V., Dahlberg, P. S., Peterson, M., Smith, K. A., Polunovsky, V. A., Bitterman, P. B., et al. (2009) · ACS Chemical Biology · doi:10.1021/cb9000475 · Cited by 86 · see citing works
Synthetic Silvestrol Analogues as Potent and Selective Protein Synthesis Inhibitors
Liu, T., Nair, S. J., Lescarbeau, A., Belani, J. D., Peluso, S., Conley, J., Tillotson, B. P., O’Hearn, P. J., Smith, S. A., Slocum, K. L., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3011542 · Cited by 86 · see citing works
Diab, S., Teo, T., Kumarasiri, M., Li, P., Yu, M., Lam, F., Basnet, S. K. C., Sykes, M. J., Albrecht, H., Milne, R. W., et al. (2014) · ChemMedChem · doi:10.1002/cmdc.201300552 · Cited by 85 · see citing works
Rapid induction of apoptosis mediated by peptides that bind initiation factor eIF4E
Herbert, T. P., Fåhræus, R., Prescott, A. R., Lane, D. P., & Proud, C. G. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00567-4 · Cited by 85 · see citing works
Dmitriev, S. E., Terenin, I. M., Dunaevsky, Y. E., Merrick, W. C., & Shatsky, I. N. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.8925-8933.2003 · Cited by 85 · see citing works
AGC kinases regulate phosphorylation and activation of eukaryotic translation initiation factor 4B
van Gorp, A. G. M., van der Vos, K. E., Brenkman, A. B., Bremer, A., van den Broek, N. J. F., Zwartkruis, F. J. T., Hershey, J. W. B., Burgering, B. M. T., Calkhoven, C. F., & Coffer, P. J. (2008) · Oncogene · doi:10.1038/onc.2008.367 · Cited by 85 · see citing works
Tomoo, K., Shen, X., Okabe, K., et al. (2002) · Biochemical Journal · doi:10.1042/bj3620539 · Cited by 85 · see citing works
Rinker-Schaeffer, C. W., Austin, V. N., Zimmer, S. G., & Rhoads, R. E. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50068-0 · Cited by 83 · see citing works
Abramson, R. D., Dever, T. E., & Merrick, W. C. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68741-1 · Cited by 82 · see citing works
Gupta, S. V., Sass, E. J., Davis, M. E., Edwards, R. B., Lozanski, G., Heerema, N. A., Lehman, A., Zhang, X., Jarjoura, D., Byrd, J. C., et al. (2011) · The AAPS Journal · doi:10.1208/s12248-011-9276-7 · Cited by 81 · see citing works
eIF4F suppression in breast cancer affects maintenance and progression
Nasr, Z., Robert, F., Porco, J. A. J., Muller, W. J., & Pelletier, J. (2012) · Oncogene · doi:10.1038/onc.2012.105 · Cited by 81 · see citing works
Self-citationTargeting the eIF4A RNA helicase as an anti-neoplastic approach
Chu, J., & Pelletier, J. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.09.006 · Cited by 80 · see citing works
Self-citationKroczynska, B., Kaur, S., Katsoulidis, E., Majchrzak-Kita, B., Sassano, A., Kozma, S., Fish, E., & Platanias, L. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01537-08 · Cited by 79 · see citing works
Adaptation to mTOR kinase inhibitors by amplification of eIF4E to maintain cap-dependent translation
Cope, C. L., Gilley, R., Balmanno, K., Sale, M. J., Howarth, K., Hampson, M., Smith, P. D., Guichard, S. M., & Cook, S. J. (2013) · Journal of Cell Science · doi:10.1242/jcs.137588 · Cited by 79 · see citing works
Depletion of eIF4G from yeast cells narrows the range of translational efficiencies genome-wide
Park, E.-H., Zhang, F., Warringer, J., Sunnerhagen, P., & Hinnebusch, A. G. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-68 · Cited by 74 · see citing works
General RNA‐binding proteins have a function in poly(A)‐binding protein‐dependent translation
Svitkin, Y. V., Evdokimova, V. M., Brasey, A., Pestova, T. V., Fantus, D., Yanagiya, A., Imataka, H., Skabkin, M. A., Ovchinnikov, L. P., Merrick, W. C., et al. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.259 · Cited by 74 · see citing works
Self-citationBi, X., & Goss, D. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909464199 · Cited by 73 · see citing works
Edery, I., Lee, K. A. W., & Sonenberg, N. (1984) · Biochemistry · doi:10.1021/bi00306a021 · Cited by 73 · see citing works
Self-citationJemielity, J., Kowalska, J., Rydzik, A. M., & Darżynkiewicz, E. (2010) · New Journal of Chemistry · doi:10.1039/c0nj00041h · Cited by 73 · see citing works
Slepenkov, S. V., Darżynkiewicz, E., & Rhoads, R. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601653200 · Cited by 71 · see citing works
Therapeutic Potential of the Translation Inhibitor Silvestrol in Hepatocellular Cancer
Kogure, T., Kinghorn, A. D., Yan, I. K., Bolon, B. N., Lucas, D. M., Grever, M. R., & Patel, T. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076136 · Cited by 68 · see citing works
Modifying chemotherapy response by targeted inhibition of eukaryotic initiation factor 4A
Cencic, R., Robert, F., Galicia-Vázquez, G., Malina, A., Kontham, R., Somaiah, R., Pierre, P., Tanaka, J., Deslongchamps, P., & Pelletier, J. (2013) · Blood Cancer Journal · doi:10.1038/bcj.2013.25 · Cited by 67 · see citing works
Self-citationBi, X., Ren, J., & Goss, D. J. (2000) · Biochemistry · doi:10.1021/bi992322p · Cited by 67 · see citing works
Thomas, A. A. M., GOUMANS, H., AMESZ, H., Benne, R., & Voorma, H. O. (1979) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1979.tb13192.x · Cited by 67 · see citing works
RNA-binding activity of translation initiation factor eIF4G1 from Saccharomyces cerevisiae
Berset, C., Zurbriggen, A., Djafarzadeh, S., Altmann, M., & Trachsel, H. (2003) · RNA · doi:10.1261/rna.5380903 · Cited by 67 · see citing works
Jiang, Y., & Muschel, R. J. (2002) · PubMed · Cited by 66 · see citing works
Zuberek, J., Jemielity, J., Jabłonowska, A., Stȩpiński, J., Dadlez, M., Stolarski, R., & Darżynkiewicz, E. (2004) · Biochemistry · doi:10.1021/bi030266t · Cited by 65 · see citing works
Emerging Therapeutics Targeting mRNA TranslationPreprint
Malina, A., Mills, J. R., & Pelletier, J. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a012377 · Cited by 65 · see citing works
Self-citationTranslation initiation factor eIF4F modifies the dexamethasone response in multiple myeloma
Robert, F., Roman, W., Bramoullé, A., Fellmann, C., Roulston, A., Shustik, C., Porco, J. A., Shore, G. C., Sebag, M., & Pelletier, J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402650111 · Cited by 64 · see citing works
Self-citationLarsson, O. S., Perlman, D., Fan, D., Reilly, C., Peterson, M., Dahlgren, C., Liang, Z., Li, S., Polunovsky, V. A., Wahlestedt, C., et al. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl558 · Cited by 64 · see citing works
Characterization of the 46,000-Dalton subunit of eIF-4F
Conroy, S. C., Dever, T. E., Owens, C. L., & Merrick, W. C. (1990) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(90)90130-q · Cited by 63 · see citing works
Tschopp, C., Knauf, U., Brauchle, M. A., Zurini, M. G. M., Ramage, P., Glück, D., New, L., Han, J., & Gram, H. (2000) · Molecular Cell Biology Research Communications · doi:10.1006/mcbr.2000.0217 · Cited by 63 · see citing works
Morgan, M. A., & Shatkin, A. J. (1980) · Biochemistry · doi:10.1021/bi00567a003 · Cited by 62 · see citing works
Single-Molecule Kinetics of the Eukaryotic Initiation Factor 4AI upon RNA Unwinding
Sun, Y., Atas, E., Lindqvist, L., Sonenberg, N., Pelletier, J., & Meller, A. (2014) · Structure · doi:10.1016/j.str.2014.04.014 · Cited by 56 · see citing works
Self-citationPelletier, J., & Sonenberg, N. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.11.3222 · Cited by 56 · see citing works
Self-citationPreferential stimulation of rabbit α globin mRNA translation by a cap-binding protein complex
Sarkar, G., Edery, I., Gallo, R., & Sonenberg, N. (1984) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(84)90003-4 · Cited by 55 · see citing works
Self-citationCap-dependent eukaryotic initiation factor-mRNA interactions probed by cross-linking
Lindqvist, L., Imataka, H., & Pelletier, J. (2008) · RNA · doi:10.1261/rna.971208 · Cited by 55 · see citing works
Self-citationExpression of eIF4E During Head and Neck Tumorigenesis: Possible Role in Angiogenesis
Nathan, C. O., Franklin, S. W., Abreo, F. W., Nassar, R., Benedetti, A. D., Williams, J., & Stucker, F. J. (1999) · The Laryngoscope · doi:10.1097/00005537-199908000-00013 · Cited by 54 · see citing works
Rotili, D., Tarantino, D., Artico, M., Nawrozkij, M. B., González-Ortega, E., Clotet, B., Samuele, A., Esté, J. A., Maga, G., & Mai, A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101626c · Cited by 53 · see citing works
Flagged first, then by citations
7 of the 227 references couldn’t be matched to a known paper.
Research works printed but not linked: 4
- [122]Wendel HG De Stanchina E Fridman JS Malina A Ray S Kogan S Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy Nature 2004 428 6980 332 7 15029198
- [127]Nasr Z Robert F Porco JA Jr Muller WJ Pelletier J eIF4F suppression in breast cancer affects maintenance and progression Oncogene 2013 32 7 861 71 22484424 PMC4863948
- [158]DeFatta RJ Nathan CA De Benedetti A Antisense RNA to eIF4E suppresses oncogenic properties of a head and neck squamous cell carcinoma cell line Laryngoscope 2000 110 6 928 33 10852506
- [195]Konicek BW Stephens JR McNulty AM Robichaud N Peery RB Dumstorf CA Therapeutic inhibition of MAP kinase interacting kinase blocks eukaryotic initiation factor 4E phosphorylation and suppresses outgrowth of experimental lung metastases Cancer research 2011 71 5 1849 57 21233335
Cited by
Sorted by citations
ERK signalling: A master regulator of cell behaviour, life and fate
Lavoie, H., Gagnon, J., & Therrien, M. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0255-7 · Cited by 1,185 · see citing works
NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer
Chio, I. I. C., Jafarnejad, S. M., Ponz-Sarvise, M., Park, Y., Rivera, K., Palm, W., Wilson, J., Sangar, V., Hao, Y., Öhlund, D., et al. (2016) · Cell · doi:10.1016/j.cell.2016.06.056 · Cited by 378 · see citing works
“Of the four phases of protein synthesis (initiation, elongation, termination, and recycling), initiation is considered to be the rate-limiting step in mRNA translation and is often exploited by cancer cells to support tumorigenesis (Pelletier et al., 2015).”
InfluentialSelf-citationGenome editing of upstream open reading frames enables translational control in plants
Zhang, H., Si, X., Ji, X., Fan, R., Liu, J., Chen, K., Wang, D., & Gao, C. (2018) · Nature Biotechnology · doi:10.1038/nbt.4202 · Cited by 364 · see citing works
Translation from unconventional 5′ start sites drives tumour initiation
Sendoel, A., Dunn, J. G., Rodriguez, E. H., Naik, S., Gomez, N. C., Hurwitz, B. S., Levorse, J. M., Dill, B. D., Schramek, D., Molina, H., et al. (2017) · Nature · doi:10.1038/nature21036 · Cited by 330 · see citing works
Kern, L., Mittenbühler, M., Vesting, A., Ostermann, A., Wunderlich, C., & Wunderlich, F. (2018) · Cancers · doi:10.3390/cancers11010024 · Cited by 331 · see citing works
The SARS-CoV-2 RNA–protein interactome in infected human cells
Schmidt, N., Lareau, C. A., Keshishian, H., Ganskih, S., Schneider, C., Hennig, T., Melanson, R., Werner, S., Wei, Y., Zimmer, M. M., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-00846-z · Cited by 320 · see citing works
Cytoplasmic stress granules: Dynamic modulators of cell signaling and disease
Mahboubi, H., & Stochaj, U. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.12.022 · Cited by 288 · see citing works
Translational control of tumor immune escape via the eIF4F–STAT1–PD-L1 axis in melanoma
Cerezo, M., Guemiri, R., Druillennec, S., Girault, I., Malka-Mahieu, H., Shen, S., Allard, D., Martineau, S., Welsch, C., Agoussi, S., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0217-1 · Cited by 249 · see citing works
Self-citationPadrón, A., Iwasaki, S., & Ingolia, N. T. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.07.030 · Cited by 245 · see citing works
Alternative approaches to target Myc for cancer treatment
Wang, C., Zhang, J., Yin, J., Gan, Y., Xu, S., Gu, Y., & Huang, W. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00500-y · Cited by 243 · see citing works
Proteome complexity and the forces that drive proteome imbalance
Harper, J. W., & Bennett, E. J. (2016) · Nature · doi:10.1038/nature19947 · Cited by 234 · see citing works
Exploring the Impact of Single-Nucleotide Polymorphisms on Translation
Robert, F., & Pelletier, J. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00507 · Cited by 226 · see citing works
Self-citationSiddiqui, N., & Sonenberg, N. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150126 · Cited by 220 · see citing works
Self-citationHeterogeneity and specialized functions of translation machinery: from genes to organisms
Genuth, N. R., & Barna, M. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0008-z · Cited by 221 · see citing works
MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies
Ahmadi, S. E., Rahimi, S., Zarandi, B., Chegeni, R., & Safa, M. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01111-4 · Cited by 211 · see citing works
Gandin, V., Masvidal, L., Hulea, L., Gravel, S., Cargnello, M., McLaughlan, S., Cai, Y., Balanathan, P., Morita, M., Rajakumar, A., et al. (2016) · Genome Research · doi:10.1101/gr.197566.115 · Cited by 200 · see citing works
Self-citationPausing on Polyribosomes: Make Way for Elongation in Translational Control
Richter, J. D., & Coller, J. M. (2015) · Cell · doi:10.1016/j.cell.2015.09.041 · Cited by 204 · see citing works
Müller, C., Schulte, F. W., Lange‐Grünweller, K., Obermann, W., Madhugiri, R., Pleschka, S., Ziebuhr, J., Hartmann, R. K., & Grünweller, A. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2017.12.010 · Cited by 203 · see citing works
Cancer the‘RBP’eutics–RNA-binding proteins as therapeutic targets for cancer
Mohibi, S., Chen, X., & Zhang, J. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.07.001 · Cited by 200 · see citing works
Reich, S., Sprengeler, P. A., Chiang, G. G., Appleman, J. R., Chen, J. W., Clarine, J., Eam, B., Ernst, J. T., Han, Q., Goel, V., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01795 · Cited by 185 · see citing works
Merrick, W. C. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.675280 · Cited by 176 · see citing works
How Ribosomes Translate Cancer
Sulima, S. O., Hofman, I. J., Keersmaecker, K. D., & Dinman, J. D. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0550 · Cited by 174 · see citing works
Aptamers: Uptake mechanisms and intracellular applications
Yoon, S., & Rossi, J. J. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.003 · Cited by 171 · see citing works
Onset of differentiation is post-transcriptionally controlled in adult neural stem cells
Baser, A., Skabkin, M. A., Kleber, S., Dang, Y., Balta, G. S. G., Kalamakis, G., Göpferich, M., Ibañez, D. C., Schefzik, R., Lopez, A. S., et al. (2019) · Nature · doi:10.1038/s41586-019-0888-x · Cited by 161 · see citing works
Ernst, J. T., Thompson, P. A., Nilewski, C., Sprengeler, P. A., Sperry, S., Packard, G., Michels, T., Xiang, A., Tran, C., Wegerski, C. J., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00182 · Cited by 150 · see citing works
Tailor made: the art of therapeutic mRNA design
Metkar, M., Pepin, C. S., & Moore, M. J. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00827-x · Cited by 153 · see citing works
Translation initiation by cap‐dependent ribosome recruitment: Recent insights and open questions
Shirokikh, N. E., & Preiß, T. (2018) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1473 · Cited by 143 · see citing works
Abbas, Y. M., Laudenbach, B. T., Martínez‐Montero, S., Cencic, R., Habjan, M., Pichlmair, A., Damha, M. J., Pelletier, J., & Nagar, B. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612444114 · Cited by 133 · see citing works
Self-citationTranslation Initiation Factors: Reprogramming Protein Synthesis in Cancer
Chu, J., Cargnello, M., Topisirović, I., & Pelletier, J. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.06.005 · Cited by 127 · see citing works
Self-citationThe oncomicropeptide APPLE promotes hematopoietic malignancy by enhancing translation initiation
Sun, L.-Y., Wang, W., Han, C., Huang, W., Sun, Y., Fang, K., Zeng, Z., Yang, Q., Pan, Q., Chen, T., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.033 · Cited by 126 · see citing works
Guzzi, N., Muthukumar, S., Cieśla, M., Todisco, G., Ngoc, P. C. T., Madej, M., Munita, R., Fazio, S., Ekström, S., Blanco, T. M., et al. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00852-9 · Cited by 124 · see citing works
Quan, Z., Yang, Y., Zheng, H., Zhan, Y., Luo, J., Ning, Y., & Fan, S. (2022) · Journal of Cancer · doi:10.7150/jca.77619 · Cited by 124 · see citing works
Sorafenib, a multikinase inhibitor, induces formation of stress granules in hepatocarcinoma cells
Adjibade, P., St-Sauveur, V. G., Huberdeau, M. Q., Fournier, M., Savard, A., Coudert, L., Khandjian, É. W., & Mazrouï, R. (2015) · Oncotarget · doi:10.18632/oncotarget.5980 · Cited by 114 · see citing works
eIF4A supports an oncogenic translation program in pancreatic ductal adenocarcinoma
Chan, K., Robert, F., Oertlin, C., Kapeller-Libermann, D., Avizonis, D., Gutierrez, J., Handly-Santana, A., Doubrovin, M., Park, J., Schoepfer, C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13086-5 · Cited by 106 · see citing works
Self-citationEukaryotic translation initiation factors as promising targets in cancer therapy
Hao, P., Yu, J.-J., Ward, R., Liu, Y., Hao, Q., An, S., & Xu, T.-R. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00607-9 · Cited by 95 · see citing works
Wanted DEAD/H or Alive: Helicases Winding Up in Cancers
Cai, W., Chen, Z.-X., Rane, G., Singh, S. S., Choo, Z., Wang, C., Yuan, Y., Tan, T. Z., Arfuso, F., Yap, C., et al. (2017) · Journal of the National Cancer Institute · doi:10.1093/jnci/djw278 · Cited by 114 · see citing works
Translation acrobatics: how cancer cells exploit alternate modes of translational initiation
Sriram, A., Bohlen, J., & Teleman, A. A. (2018) · EMBO Reports · doi:10.15252/embr.201845947 · Cited by 106 · see citing works
Molecular Pathways: The eIF4F Translation Initiation Complex—New Opportunities for Cancer Treatment
Malka-Mahieu, H., Newman, M., Désaubry, L., Robert, C., & Vagner, S. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2362 · Cited by 105 · see citing works
Translational control of aberrant stress responses as a hallmark of cancer
El-Naggar, A. M., & Sorensen, P. H. B. (2018) · The Journal of Pathology · doi:10.1002/path.5030 · Cited by 102 · see citing works
The natural compound silvestrol is a potent inhibitor of Ebola virus replication
Biedenkopf, N., Lange‐Grünweller, K., Schulte, F. W., Weißer, A., Müller, C., Becker, D., Becker, S., Hartmann, R. K., & Grünweller, A. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.11.011 · Cited by 102 · see citing works
Ma, X., Li, B., Liu, J., Fu, Y., & Luo, Y. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1053-y · Cited by 97 · see citing works
Stress granule: A promising target for cancer treatment
Gao, X., Jiang, L., Gong, Y., Chen, X., Ying, M., Zhu, H., He, Q., Yang, B., & Cao, J. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14790 · Cited by 93 · see citing works
Chen, H.-H., Yu, H.-I., Yang, M., & Tarn, W. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0282 · Cited by 90 · see citing works
Targeting RNA helicases in cancer: The translation trap
van Voss, M. R. H., van Diest, P. J., & Raman, V. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.09.006 · Cited by 87 · see citing works
Combinatorial Control of mRNA Fates by RNA-Binding Proteins and Non-Coding RNAs
Iadevaia, V., & Gerber, A. P. (2015) · Biomolecules · doi:10.3390/biom5042207 · Cited by 79 · see citing works
Xu, Z., Tian, P., Guo, J., Mi, C., Liang, T., Xie, J., Huang, W., Dai, M., Chen, W., & Zhang, H. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.145950 · Cited by 76 · see citing works
Tahmasebi, S., Jafarnejad, S. M., Tam, I. S., Gonatopoulos-Pournatzis, T., Matta‐Camacho, E., Tsukumo, Y., Yanagiya, A., Li, W., Atlasi, Y., Caron, M., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1615540113 · Cited by 75 · see citing works
Self-citationCatalysis-Based Total Syntheses of Pateamine A and DMDA-Pat A
Zhuo, C., & Fürstner, A. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b05094 · Cited by 75 · see citing works
Control of the eIF4E activity: structural insights and pharmacological implications
Romagnoli, A., D’Agostino, M., Ardiccioni, C., Maracci, C., Motta, S., Teana, A. L., & Marino, D. D. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03938-z · Cited by 70 · see citing works
mTOR-sensitive translation: Cleared fog reveals more trees
Masvidal, L., Hulea, L., Furic, L., Topisirović, I., & Larsson, O. S. (2017) · RNA Biology · doi:10.1080/15476286.2017.1290041 · Cited by 68 · see citing works
eIF4E-Dependent Translational Control: A Central Mechanism for Regulation of Pain Plasticity
Uttam, S., Wong, C., Price, T. J., & Khoutorsky, A. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00470 · Cited by 75 · see citing works
Mlakar, V., Morel, E., Mlakar, S. J., Ansari, M., & Gumy‐Pause, F. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01967-x · Cited by 69 · see citing works
PABPC1——mRNA stability, protein translation and tumorigenesis
Qi, Y., Wang, M., & Jiang, Q. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1025291 · Cited by 68 · see citing works
Vaklavas, C., Blume, S. W., & Grizzle, W. E. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00158 · Cited by 71 · see citing works
Stress granules: functions and mechanisms in cancer
Zhou, H., Luo, J., Mou, K., Peng, L., Li, X., Lei, Y., Wang, J., Lin, S., Luo, Y., & Li, X. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01030-6 · Cited by 72 · see citing works
Inhibition of Zika Virus Replication by Silvestrol
Elgner, F., Sabino, C., Basic, M., Ploen, D., Grünweller, A., & Hildt, E. (2018) · Viruses · doi:10.3390/v10040149 · Cited by 71 · see citing works
The 4E-BP–eIF4E axis promotes rapamycin-sensitive growth and proliferation in lymphocytes
So, L., Lee, J., Palafox, M., Mallya, S., Woxland, C. G., Arguello, M., Truitt, M., Sonenberg, N., Ruggero, D., & Fruman, D. A. (2016) · Science Signaling · doi:10.1126/scisignal.aad8463 · Cited by 69 · see citing works
Self-citationEukaryotic translation initiation factors and cancer
Ali, M. U., Rahman, M. S. U., Jia, Z., & Jiang, C. (2017) · Tumor Biology · doi:10.1177/1010428317709805 · Cited by 69 · see citing works
Yeomans, A., Thirdborough, S. M., Valle‐Argos, B., Linley, A. J., Krysov, S. V., Sánchéz‐Hidalgo, M., Leonard, E., Ishfaq, M., Wagner, S. D., Willis, A. E., et al. (2015) · Blood · doi:10.1182/blood-2015-07-660969 · Cited by 66 · see citing works
RNA binding proteins (RBPs) and their role in DNA damage and radiation response in cancer
Mehta, M., Raguraman, R., Ramesh, R., & Munshi, A. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114569 · Cited by 67 · see citing works
Could the eIF2α-Independent Translation Be the Achilles Heel of Cancer?
Holčı́k, M. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00264 · Cited by 65 · see citing works
Yang, H., Chennamaneni, L. R., Ho, M. W. T., Ang, S. H., Tan, E. S. W., Jeyaraj, D. A., Yeap, Y. S., Liu, B., Ong, E. H., Joy, J. K., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01714 · Cited by 64 · see citing works
Chen, Z., Qi, J.-J., Wu, Q., Lu, J., Liu, Z., Wang, Y., Hu, P., Li, T., Lin, J., Wu, X., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1178-z · Cited by 63 · see citing works
Hippuristanol - A potent steroid inhibitor of eukaryotic initiation factor 4A
Cencic, R., & Pelletier, J. (2016) · Translation · doi:10.1080/21690731.2015.1137381 · Cited by 63 · see citing works
Self-citationGeneral and Target-Specific DExD/H RNA Helicases in Eukaryotic Translation Initiation
Shen, L. L., & Pelletier, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124402 · Cited by 63 · see citing works
Self-citationTranslational dysregulation in cancer: eIF4A isoforms and sequence determinants of eIF4A dependence
Raza, F., Waldron, J. A., & Quesne, J. L. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150163 · Cited by 61 · see citing works
Oncogene-dependent sloppiness in mRNA translation
Champagne, J., Pataskar, A., Blommaert, N., Nagel, R., Wernaart, D., Ramalho, S., Kenski, J. C. N., Bleijerveld, O. B., Zaal, E. A., Berkers, C. R., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.09.002 · Cited by 63 · see citing works
Tiu, G. C., Kerr, C. H., Forester, C. M., Krishnarao, P. S., Rosenblatt, H. D., Raj, N., Lantz, T. C., Zhulyn, O., Bowen, M. E., Shokat, L., et al. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.06.013 · Cited by 57 · see citing works
Self-citationHuang, Y., Zhen, Y., Chen, Y., Sui, S., & Zhang, L. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115842 · Cited by 59 · see citing works
MicroRNA-455-3p functions as a tumor suppressor by targeting eIF4E in prostate cancer
Zhao, Y., Yan, M., Ye, Y., Zhang, J., Zhang, R., Li, Y., Wu, X., Liu, Q., Miao, W., & Jiang, H. (2017) · Oncology Reports · doi:10.3892/or.2017.5502 · Cited by 58 · see citing works
Role of stress granules in tumorigenesis and cancer therapy
Li, T., Zeng, Z., Fan, C., & Xiong, W. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189006 · Cited by 56 · see citing works
Waldron, J. A., Tack, D. C., Ritchey, L. E., Gillen, S. L., Wilczynska, A., Turro, E., Bevilacqua, P. C., Assmann, S. M., Bushell, M., & Quesne, J. P. C. L. (2019) · Genome biology · doi:10.1186/s13059-019-1901-2 · Cited by 56 · see citing works
Geter, P. A., Ernlund, A. W., Bakogianni, S., Alard, A., Arju, R., Giashuddin, S. M., Gadi, A., Bromberg, J., & Schneider, R. J. (2017) · Genes & Development · doi:10.1101/gad.305631.117 · Cited by 55 · see citing works
Expression and Functional Roles of Eukaryotic Initiation Factor 4A Family Proteins in Human Cancers
Xue, C., Gu, X.-Y., Li, G., Bao, Z., & Li, L.-J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.711965 · Cited by 40 · see citing works
Anderson, G. R., Wardell, S. E., Cakir, M., Crawford, L., Leeds, J. C., Nussbaum, D. P., Shankar, P. S., Soderquist, R. S., Stein, E. M., Tingley, J. P., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aae0348 · Cited by 53 · see citing works
Mechanisms Underlying Muscle Protein Imbalance Induced by Alcohol
Kimball, S. R., & Lang, C. H. (2018) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071816-064642 · Cited by 53 · see citing works
Kumar, K., Chow, C. R., Ebine, K., Arslan, A. D., Kwok, B., Bentrem, D. J., Eckerdt, F., Platanias, L. C., & Munshi, H. G. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0285 · Cited by 52 · see citing works
Carter, J. H., Deddens, J. A., Spaulding, N. R., Lucas, D., Colligan, B. M., Lewis, T. G., Hawkins, E., Jones, J., Pemberton, J. O., Douglass, L. E., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2015.450 · Cited by 49 · see citing works
Self-citationAssembly of eIF3 Mediated by Mutually Dependent Subunit Insertion
Smith, M. D., de Tacca, L. A., Nitido, A. D., Montabana, E. A., Park, A., & Cate, J. H. D. (2016) · Structure · doi:10.1016/j.str.2016.02.024 · Cited by 52 · see citing works
Iaconis, D., Monti, M., Renda, M., van Koppen, A., Tammaro, R., Chiaravalli, M., Cozzolino, F., Pignata, P., Crina, C., Pucci, P., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01156-x · Cited by 52 · see citing works
Silvestrol Inhibits Chikungunya Virus Replication
Henß, L., Scholz, T., Grünweller, A., & Schnierle, B. S. (2018) · Viruses · doi:10.3390/v10110592 · Cited by 51 · see citing works
Dysregulation of mRNA translation and energy metabolism in cancer
Leibovitch, M., & Topisirović, I. (2017) · Advances in Biological Regulation · doi:10.1016/j.jbior.2017.11.001 · Cited by 46 · see citing works
Targeting of the Eukaryotic Translation Initiation Factor 4A Against Breast Cancer Stemness
Sridharan, S., Robeson, M., Tukaramrao, D. B., Howard, C. M., Subramaniyan, B., Tilley, A. M. C., Tiwari, A. K., & Raman, D. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01311 · Cited by 49 · see citing works
eIF4AII is dispensable for miRNA-mediated gene silencing
Galicia-Vázquez, G., Chu, J., & Pelletier, J. (2015) · RNA · doi:10.1261/rna.052225.115 · Cited by 48 · see citing works
Self-citationInhibiting 4EBP1 in Glioblastoma
Fan, Q. W., Nicolaides, T. P., & Weiss, W. A. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0042 · Cited by 48 · see citing works
LRRK2 regulates retrograde synaptic compensation at the Drosophila neuromuscular junction
Penney, J., Tsurudome, K., Liao, E. H., Kauwe, G., Gray, L. A., Yanagiya, A., Calderon, M. R., Sonenberg, N., & Haghighi, A. P. (2016) · Nature Communications · doi:10.1038/ncomms12188 · Cited by 47 · see citing works
Self-citationJaiswal, P. K., Koul, S., Palanisamy, N., & Koul, H. K. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0947-2 · Cited by 46 · see citing works
Translational Regulation of Cancer Metastasis
Micalizzi, D. S., Ebright, R. Y., Haber, D. A., & Maheswaran, S. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2720 · Cited by 46 · see citing works
Targeting BRD4 proteins suppresses the growth of NSCLC through downregulation of eIF4E expression
Gao, Z., Yuan, T., Zhou, X., Ni, P., Sun, G., Li, P., Cheng, Z., & Wang, X. (2018) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1423923 · Cited by 46 · see citing works
The TLK1-Nek1 axis promotes prostate cancer progression
Singh, V., Jaiswal, P. K., Ghosh, I., Koul, H. K., Yu, X., & Benedetti, A. D. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.03.041 · Cited by 46 · see citing works
Cotargeting MNK and MEK kinases induces the regression of NF1-mutant cancers
Lock, R., Ingraham, R., Maertens, O., Miller, A. L., Weledji, N., Legius, E., Konicek, B. W., Yan, S.-C. B., Graff, J. R., & Cichowski, K. M. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85183 · Cited by 45 · see citing works
Self-citationMechanistic/mammalian target of rapamycin: Recent pathological aspects and inhibitors
Abdel‐Maksoud, M. S., El–Gamal, M. I., Benhalilou, D. R., Ashraf, S., Mohammed, S. A., & Oh, C. (2018) · Medicinal Research Reviews · doi:10.1002/med.21535 · Cited by 45 · see citing works
Follo, C., Vidoni, C., Morani, F., Ferraresi, A., Seca, C., & Isidoro, C. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0354-2 · Cited by 45 · see citing works
Kong, T., Xue, Y., Cencic, R., Zhu, X., Monast, A., Fu, Z., Pilon, V., Sangwan, V., Guiot, M., Foulkes, W. D., et al. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0162 · Cited by 46 · see citing works
Self-citationZhao, Y., Wang, Y., Chen, W., Bai, S., Wang, P., Zheng, M., Yang, Y., Cheng, B., & Luan, Z. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02390-0 · Cited by 45 · see citing works
RNA-binding proteins in cancer drug discovery
Bertoldo, J. B., Müller, S., & Hüttelmaier, S. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103580 · Cited by 44 · see citing works
Pharmacological eEF2K activation promotes cell death and inhibits cancer progression
Gassart, A. D., Demaria, O., Panès, R., Zaffalon, L., Ryazanov, A. G., Gilliet, M. F., & Martinon, F. (2016) · EMBO Reports · doi:10.15252/embr.201642194 · Cited by 44 · see citing works
Beyond molecular tumor heterogeneity: protein synthesis takes control
y Cajal, S. R., Castellví, J., Hümmer, S., Peg, V., Pelletier, J., & Sonenberg, N. (2018) · Oncogene · doi:10.1038/s41388-018-0152-0 · Cited by 44 · see citing works
Self-citationThe pathogenesis of mesothelioma is driven by a dysregulated translatome
Grosso, S., Marini, A., Gyurászová, K., Voorde, J. V., Sfakianos, A., Garland, G. D., Rubio, A., Mordue, R., Chernova, T., Morone, N., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25173-7 · Cited by 43 · see citing works
Key contribution of eIF4H-mediated translational control in tumor promotion
Vaysse, C., Philippe, C., Martineau, Y., Quelen, C., Hiéblot, C., Renaud, C., Nicaise, Y., Desquesnes, A., Pannese, M., Filleron, T., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5442 · Cited by 43 · see citing works
- Authors
- Pelletier, J., Graff, J., Ruggero, D., & Sonenberg, N.
- Affiliations
- Institut du cancer Rosalind & Morris Goodman (CA)
- Eli Lilly (United States) (US)
- University of California, San Francisco (US)
- Corresponding author
- Pelletier, Jerry
- Venue
- Cancer Research
- Published
- 2015-01-14
- Volume
- 75
- Issue
- 2
- Pages
- 250-263
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- PMC
- PMC4299928
- OpenAlex
- W2005176113
- Cited by
- 367
- References
- 227
- Citations by year
- 2026: 18 · 2025: 18 · 2024: 30 · 2023: 36 · 2022: 30 · 2021: 39 · 2020: 32 · 2019: 35 · 2018: 40 · 2017: 33 · 2016: 37 · 2015: 19
- FWCI
- 4.17
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship@McGill (McGill) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- U.S. Public Health Service (MOP-106530, MOP-115126)
- National Cancer Institute (R01CA140456, R01CA184624, R01CA154916)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
- Keywords
- eIF4F, translation initiation, cancer, translational regulation, oncogenic signaling, Ras, c-Myc, metastasis, epithelial-mesenchymal transition, angiogenesis, cell proliferation
- MeSH terms
- Animals, Antineoplastic Agents, Humans, Neoplasms, Eukaryotic Initiation Factor-4F, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review